SCHEMBL9608326

SCHEMBL9608326

Cc1cccc(-c2ccc(Cn3cc4c(=O)n(C)c(=O)n(CC(C)(C)C)c4c3Nc3ccccc3)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1B Q01064 4/20 0.44
GRM2 Q14416 8/20 0.39
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 1/20 0.36
PDE1A P54750 3/20 0.34
PDE1C Q14123 3/20 0.34
PDE4A P27815 2/20 0.33
ADORA2B P29275 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
PDE2A O00408 2/20 0.33
POLB P06746 1/20 0.33
HIF1A Q16665 1/20 0.33
STK4 Q13043 1/20 0.33
STK3 Q13188 1/20 0.33
SIK2 Q9H0K1 1/20 0.33
STK26 Q9P289 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2456668 0.91 PDE1B (0.54) PDE1BGRM2KDM4EALDH1A1GAA
SCHEMBL9608321 0.89 PDE1B (0.45) PDE1BKDM4EALDH1A1GAAMAPK1
SCHEMBL2451829 0.80 PDE1B (0.54) PDE1BPDE1APDE1CPDE4AADORA2B
SCHEMBL8513322 0.77 PDE1B (0.46) PDE1BPDE1APDE1CPDE4AADORA2B
SCHEMBL9608338 0.72 PDE1B (0.44) PDE1BPDE1APDE1CPDE4AADORA2B
SCHEMBL2455782 0.71 PDE1B (0.42) PDE1BPDE1APDE1CPDE4AADORA2B
SCHEMBL2452774 0.71 PDE1B (0.41) PDE1BALDH1A1HPGDPDE1APDE1C
SCHEMBL2460367 0.71 PDE1A (0.45) PDE1BKDM4EALDH1A1PDE1APDE1C
SCHEMBL2454552 0.70 PDE1A (0.46) PDE1BALDH1A1MAPK1PDE1APDE1C
SCHEMBL3000045 0.68 PDE1B (0.60) PDE1BGRM2PDE1APDE1CPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150353556-A1 ORGANIC COMPOUNDS LI PENG (US) 2015-12-10 US disclosed
US-8927556-B2 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds INTRA-CELLULAR THERAPIES, INC. (US) 2015-01-06 US disclosed
US-20120136013-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES. INC. 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353556-A1 ORGANIC COMPOUNDS CYP2C9, TPMT, CYP2C19 PDE1B 4863/4885GRM2 3711/4885KDM4E 1898/4885
US-20120136013-A1 ORGANIC COMPOUNDS CYP2C9, CYP2C19, CYP3A4 PDE1B 4855/4885GRM2 3619/4885KDM4E 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.